Corient Private Wealth LP Buys 423,039 Shares of Rocket Lab Corporation $RKLB

Key Points

• Corient Private Wealth LP increased its Rocket Lab stake by 795.2% in the second quarter, acquiring 423,039 additional shares and bringing its total holdings to 476,241 shares valued at approximately $48.4 million. Institutional investors collectively own 71.78% of the company.
• Insider selling remains a significant concern: executives sold 3.62 million shares worth about $312.9 million over the past 90 days, including sizable sales by the CFO and a senior vice president under pre-arranged Rule 10b5-1 plans.
• Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and an average price target of $107.32, although Rocket Lab recently missed its quarterly EPS estimate and continues to post negative earnings and margins.

Corient Private Wealth LP grew its position in Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 795.2% in the second quarter, according to its most recent filing with the SEC. The fund owned 476,241 shares of the rocket manufacturer's stock after acquiring an additional 423,039 shares during the period. Corient Private Wealth LP owned 0.08% of Rocket Lab worth $48,410,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. AQR Capital Management LLC raised its position in Rocket Lab by 114.0% in the first quarter. AQR Capital Management LLC now owns 174,308 shares of the rocket manufacturer's stock valued at $3,117,000 after purchasing an additional 92,849 shares during the last quarter. NewEdge Advisors LLC increased its stake in shares of Rocket Lab by 1,812.1% in the first quarter. NewEdge Advisors LLC now owns 36,807 shares of the rocket manufacturer's stock valued at $658,000 after buying an additional 34,882 shares during the period. Jones Financial Companies Lllp increased its stake in shares of Rocket Lab by 53.8% in the first quarter. Jones Financial Companies Lllp now owns 15,745 shares of the rocket manufacturer's stock valued at $282,000 after buying an additional 5,507 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Rocket Lab by 13.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 773,548 shares of the rocket manufacturer's stock valued at $13,831,000 after buying an additional 90,758 shares during the last quarter. Finally, Focus Partners Wealth raised its holdings in Rocket Lab by 1.0% in the 1st quarter. Focus Partners Wealth now owns 67,584 shares of the rocket manufacturer's stock valued at $1,206,000 after buying an additional 681 shares during the last quarter. Institutional investors own 71.78% of the company's stock.

Insider Transactions at Rocket Lab

In other news, SVP Arjun Kampani sold 6,034 shares of the business's stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $66.65, for a total transaction of $402,166.10. Following the completion of the sale, the senior vice president owned 250,917 shares in the company, valued at $16,723,618.05. The trade was a 2.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Adam Spice sold 140,157 shares of the company's stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $62.63, for a total value of $8,778,032.91. Following the transaction, the chief financial officer directly owned 1,155,967 shares in the company, valued at $72,398,213.21. The trade was a 10.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 3,624,371 shares of company stock valued at $312,944,881. Company insiders own 8.40% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Morgan Stanley reissued an "overweight" rating on shares of Rocket Lab in a report on Wednesday, July 8th. Wall Street Zen downgraded shares of Rocket Lab from a "hold" rating to a "sell" rating in a research note on Saturday, August 15th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Rocket Lab in a report on Friday, July 17th. KeyCorp reissued an "overweight" rating on shares of Rocket Lab in a research note on Tuesday, August 11th. Finally, KGI Securities upgraded Rocket Lab from a "neutral" rating to an "outperform" rating and set a $107.00 price objective for the company in a report on Monday, July 27th. Four equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $107.32.

More Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Successful Electron launch supports near-term momentum. Rocket Lab deployed a confidential customer’s Earth-observation satellite into a 500-kilometer orbit. The mission was the company’s 95th Electron launch overall and its 16th this year, highlighting a reliable launch cadence in a capacity-constrained market. Another commercial launch is planned before the end of September. Rocket Lab Successfully Launches 16th Electron Mission
• Positive Sentiment: Analysts see substantial upside potential. Raymond James identified two opportunities with significant upside, while multiple analysts maintain Strong Buy ratings and price targets well above the current trading level. The bullish case is supported by Rocket Lab’s record revenue, expanding backlog, and more than $1 billion in new contracts since the second quarter began. Why Raymond James Is Betting Big on Rocket Lab
• Neutral Sentiment: The investment case depends on Neutron. Commentary argues Rocket Lab’s established launch and space-systems operations could justify taking the risk on its reusable Neutron medium-lift rocket. The company’s core business is improving, but Neutron’s development schedule has not changed, leaving investors focused on execution and potential delays. Rocket Lab's Core Business Makes the Neutron Gamble Worth Taking
• Negative Sentiment: Recent underperformance reflects company-specific concerns. RKLB declined sharply from mid-June through September 10 despite record revenue and new contracts, substantially underperforming major defense peers. The drop suggests investors remain concerned about Neutron execution, elevated expectations, and the stock’s high-risk valuation. What's Behind the RKLB Drop?
• Negative Sentiment: Insider selling is a notable overhang. Reported activity showed 97 insider sales and no purchases over the past six months, including substantial sales by CEO Peter Beck and other executives. This may reinforce concerns about valuation even as operating metrics improve.

Rocket Lab Price Performance

Shares of NASDAQ RKLB opened at $62.95 on Friday. The firm's 50-day moving average price is $71.58 and its 200-day moving average price is $84.45. Rocket Lab Corporation has a 1-year low of $37.57 and a 1-year high of $151.00. The firm has a market capitalization of $37.67 billion, a P/E ratio of -233.14 and a beta of 2.60. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to analyst estimates of $231.62 million. Equities research analysts anticipate that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

About Rocket Lab

Rocket Lab USA, Inc is a space company that provides launch services and space systems for commercial, civil and national security customers. The company develops and operates launch vehicles, spacecraft and satellite components, with activities spanning the design, manufacture and operation of space hardware.

Rocket Lab's Electron rocket is a small-lift orbital launch vehicle designed to deploy small satellites. The company also develops HASTE, a suborbital test vehicle based on Electron technology, and is developing Neutron, a larger reusable launch vehicle intended to support a broader range of missions.

Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.